US Patent Issued to SOCIETE DES PRODUITS NESTLE on July 14 for "Compositions and methods for diagnosing and treating chronic kidney disease" (Missouri Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,681,023, issued on July 14, was assigned to SOCIETE DES PRODUITS NESTLE S.A. (Vevey, Switzerland).

"Compositions and methods for diagnosing and treating chronic kidney disease" was invented by Qinghong Li (Chesterfield, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods and compositions for diagnosing and enabling treatment of chronic kidney disease in a feline. In one embodiment, a method of diagnosing chronic kidney disease (CKD) in a feline can comprise measuring a normalized relative abundance or absolute quantification of a first serum biomarker and determining if the feline has CKD, early-stage CKD, or late...